Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica
Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica
Nutriband Strikes Distribution Deal With Innomedica For AVERSA Fentanyl
Nutriband Signs Exclusive Distribution Agreement With Costa Rica Based Innomedica For AVERSA Fentanyl Upon Approval And All Sports Tape Products Manufactured At Pocono Pharmaceutical / Active Intell Subsidiary
Nutriband Signs Exclusive Costa Rica Distribution Deal With Innomedica For AVERSA Fentanyl Pending Approval And Sports Tape Products, With Innomedica Funding Regulatory Approvals
Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points
The past five years for Nutriband (NASDAQ:NTRB) investors has not been profitable
Nutriband says ‘committed’ to shareholder value as ‘number one focus’
Nutriband CEO Publishes Letter to Shareholders
Nutriband CEO Publishes Letter Highlighting AVERSA Fentanyl FDA Progress, Patent Strengthening And Shareholder Value Initiatives
What's Going On With Nutriband Stock Monday?
Nutriband shares are trading higher after the company announced it signed an agreement to sell the majority stake of its subsidiary, Pocono Pharmaceutical, to EarthVision Bio.
Nutriband To Sell Majority Stake Of Subsidiary Pocono Pharmaceutical To EarthVision Bio For $5M
Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration
Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction
Nutriband Signs LOI With Qvanta Group To Explore Quantum‑AI Cybersecurity Collaboration
Nutriband Responds To Executive Order Designating Illicit Fentanyl As A Weapon Of Mass Destruction, Differentiates Prescription Transdermal Fentanyl And Highlights Aversa Fentanyl Development
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.